Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study

Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study

Aim: To examine the association between the use of incretin-based drugs [glucagon-like peptide-1 receptor agonists (GLP-1RAs), dipeptidyl peptidase-4 inhibitors (DPP-4Is)] and the risk of cholangiocarcinoma (CCA) in the United States. Methods: This large population-based, retrospective cohort study...

Full description

Saved in:
Bibliographic Details
Main Authors: Arunkumar Krishnan, Carolin V. Schneider, Hendrik-Tobias Arkenau, Ezequiel Matias Mauro, Alejandro Forner, W. Scott Butsch, Declan Walsh, Saleh A. Alqahtani
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
Incretin
Glucagon-like peptide-1 receptor agonists
Cholangiocarcinoma
Dipeptidyl peptidase 4 inhibitors
Type 2 diabetes mellitus
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623724000413
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items